MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
243 hedge funds and large institutions have $4.39B invested in Mirati Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 97 increasing their positions, 71 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 230 → 243 (+13)
20% less call options, than puts
Call options by funds: $70.3M | Put options by funds: $87.5M
Holders
243
Holding in Top 10
15
Calls
$70.3M
Puts
$87.5M
Top Buyers
| 1 | +$99.1M | |
| 2 | +$94.3M | |
| 3 | +$70.9M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$50.3M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$39.3M |
Top Sellers
| 1 | -$156M | |
| 2 | -$63.9M | |
| 3 | -$46M | |
| 4 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
-$36.3M |
| 5 |
Bank of New York Mellon
New York
|
-$32.6M |